Laboratory Specimen News
-
Creative Proteomics Introduces Innovative Absolute Quantification (AQUA) Service for Precise Protein Quantification Analysis
Creative Proteomics, a leading global provider of proteomics services, is proud to announce the launch of its innovative Absolute Quantification (AQUA) service, offering scientists a highly accurate solution for protein quantification analysis. This groundbreaking service will play a crucial role in life science research, drug development, and clinical diagnostics. Absolute Quantification (AQUA) ...
-
FireGene's Monkeypox Virus Nucleic Acid Detection Kit (Real-time PCR Method) Receives CE-IVDD Certification
FireGene announces that its Monkeypox Virus Nucleic Acid Detection Kit (Real-time Fluorescent PCR Method) has recently obtained CE-IVDD approval. This RT-PCT kit can be used to detect suspected cases of MPV infection. Rash fluid, nasopharyngeal swabs, pharyngeal swabs, and serum samples are applicable for the test. The test result is available in 40 minutes after sample collection. This kit is ...
By FireGene
-
Magnolia Medical, MHA Solutions, and Healthcare Providers Insurance Company Enter into an Exclusive, Endorsed Agreement for the Steripath Initial Specimen Diversion Device
Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 announced today that it has entered into an endorsed company agreement with MHA Solutions, a subsidiary of the Mississippi Hospital Association (MHA), and Healthcare Providers Insurance (HPIC), a reciprocal insurer that ...
-
Magnolia Medical Announces Expansion of Its Extensive Clinical Evidence Library with Six Steripath® ISDD® Studies in 2021 Demonstrating Zero or Near-Zero False Positive Sepsis Test Results
Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 today announced that six studies, reporting zero or near-zero blood culture contamination rates and up to a 31% reduction in vancomycin days of therapy (DOT) using Steripath, were submitted, accepted and published in ...
-
Magnolia Medical Further Strengthens Executive Management Team with the Addition of Silicon Valley Financial Leader, Patrick O’Malley, as Chief Financial Officer
Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 today announced the expansion of its senior leadership team with the addition of Patrick O’Malley as Chief Financial Officer. Mr. O’Malley is a seasoned public company executive bringing over three decades ...
-
Magnolia Medical Appoints Industry Veteran, Joseph Bishop, as the Senior Vice President of Operations and Product Development
Magnolia Medical Technologies, Inc., inventors of Steripath, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination for sepsis testing,1 today announced the addition of Joseph Bishop to the executive leadership team as Senior Vice President of Operations and Product Development. Mr. Bishop brings extensive and diverse medical device experience to Magnolia ...
-
GRAIL Receives New York State Approval for Galleri Multi-Cancer Early Detection Blood Test
GRAIL, LLC, a healthcare company whose mission is to detect cancer early, today announced that the New York State Department of Health (NYSDOH) has approved Galleri™, GRAIL’s groundbreaking multi-cancer early detection blood test. With NYSDOH approval, Galleri is now available to residents in the state of New York by prescription to complement existing single cancer screening tests. ...
By Grail, Inc.
-
Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program to Support Research on New Virus Strains
As scientists continue to identify new strains of the SARS-CoV-2 virus, including the B.1.1.7 UK variant that studies suggest is more transmissible, genetic sequencing is being used to track these strains and new ones that are emerging, as well as to trace transmission patterns within communities. Today, Thermo Fisher Scientific announced an extension of its SARS-CoV-2 GlobalAccess Sequencing ...
-
Thermo Fisher Scientific Expands GlobalAccess Sequencing Program
Thermo Fisher Scientific today announced the expansion of its GlobalAccess Sequencing Program to include laboratories working in oncology. Originally introduced to accelerate multi-institutional-led studies focused on SARS-CoV-2, the expanded program now provides support to labs facing significant constraints as a result of the global pandemic by offering faster access to comprehensive, ...
-
Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program
To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific today announces the SARS-CoV-2 GlobalAccess Sequencing Program for research consortia and industry groups battling the spread of the pandemic globally. Under the program, the company will provide 50 units of the Ion Torrent Genexus System at a ...
-
New Technology Leads to Decreased Hemolysis Rates
Laboratories in an increasing number of U. S. hospitals and healthcare systems are seeing significantly lower hemolysis rates in the blood specimens their staff are collecting with new technology designed for drawing blood with a single-use, sterile device that advances into the vein through a peripheral IV (PIV). The technology, PIVO (Velano Vascular, San Francisco, California), is ...
-
ASTM D2765 - 11 standard test methods for determination of gel content and swell ratio of crosslinked ethylene plastics
Many important properties of crosslinked ethylene plastics vary with the gel content. Hence, determination of the gel content provides a means of both controlling the process and rating the quality of finished products. Extraction tests permit verification of the proper gel content of any given crosslinked ethylene plastic and they also permit comparison between different ...
-
Abbott receives FDA approval for first fully automated blood test for `kissing bug` disease
Abbott received Biologic License Application (BLA) approval from the United States Food and Drug Administration (FDA) for the ABBOTT PRISM Chagas test. The test is a fully automated blood screening assay that can detect antibodies to Trypansoma cruzi (T. cruzi), a parasite found only in the Americas and most commonly acquired through contact with the blood-sucking triatomine or "kissing bug." ...
-
Brady introduces specimen labeling solution for histology and anatomic pathology labs
Brady Worldwide, Inc. (NYSE: BRC), a trusted provider for laboratory labeling, is pleased to introduce a new specimen labeling system for histology and anatomic pathology labs – the Brady Specimen Labeling Solution. With a revolutionary label attachment system and durable labels that withstand tissue processing and last up to 20 years in storage, Brady’s Specimen Labeling Solution is an ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you